Sector All sectors AI infrastructure & cloud Asset management BDC Consumer technology E-commerce Energy infrastructure Fintech & digital banking Healthcare Insurance Media, advertising & entertainment Mobility & delivery Real estate platforms REIT Semiconductors Software & cybersecurity Space & connectivity Other / unclassified A company can belong to more than one sector.
Rating history Scores 1–10 Company Alphabet (Google) · GOOG (7) Amazon · AMZN (5) Apple · AAPL (1) Ares Capital · ARCC (4) Blue Owl Capital · OWL (1) Broadcom · AVGO (1) Brookfield Asset Management · BAM (1) Capital Southwest · CSWC (2) Chime Financial · CHYM (2) CoreWeave · CRWV (1) Enbridge · ENB (1) eToro Group · ETOR (1) Figure Technology Solutions · FIGR (5) Gaming and Leisure Properties · GLPI (4) Genius Sports · GENI (3) Grab Holdings · GRAB (6) Hercules Capital · HTGC (2) Hims & Hers Health · HIMS (5) Inter & Co · INTR (4) IREN · IREN (7) MercadoLibre · MELI (5) Meta Platforms · META (6) Microsoft · MSFT (8) Nebius Group · NBIS (3) Netflix · NFLX (2) Novo Nordisk · NVO (1) Nu Holdings · NU (4) NVIDIA · NVDA (2) Palantir Technologies · PLTR (6) Pfizer · PFE (2) Prudential Financial · PRU (6) Qualcomm · QCOM (1) Realty Income · O (2) Reddit · RDDT (4) Rubrik · RBRK (2) SoFi Technologies · SOFI (6) SpaceX · SPCX (2) Sterling Infrastructure · STRL (6) Tesla · TSLA (1) Trinity Capital · TRIN (1) Uber Technologies · UBER (6) UnitedHealth Group · UNH (4) VICI Properties · VICI (1) W. P. Carey · WPC (2) Wix.com · WIX (4) Zeta Global Holdings · ZETA (6) Zillow Group · Z (5) Hims & Hers Health · Rating history Business strength horizontally, price attractiveness vertically. Dated assessments remain at their actual coordinates. Select a point or a date below for details. 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 Business strength → Price attractiveness → 10/10/2026 · Strength 5.2 / 3.0 · 30.92 USD 10/10/2026 01/11/2026 · Strength 5.2 / 4.0 · 27.68 USD 01/11/2026 11/11/2026 · Strength 5.1 / 4.4 · 19.13 USD
15/11/2026 · Strength 5.1 / 4.4 · 19.73 USD 15/11/2026 · 2 2 20/11/2026 · Strength 5.1 / 4.8 · 16.02 USD 20/11/2026 · Current Dark point: current assessment. Lighter points: older assessments. Arrows show chronological order within the same methodology. Shared points retain exact scores; tap again to cycle through dates. All dates are available below.
HIMS · Current 20/11/2026
Business strength 5.1 → 5.1 Unchanged
Price attractiveness 4.4 → 4.8 ↑ +0.4 Previous assessment: 15/11/2026
Reference price 16.02 USD close · 19/11/2026 · NYSE Methodology 1.2
The lower entry price of $16.02 improves three-year scenario returns and raises price attractiveness to 4.8/10; company strength remains 5.1/10. The Peptides+ and UK metabolic program launches expand the offering, but adoption, margins and cash contribution have not yet been quantified.
Read current analysis ↗ 10/10/2026 5.2 / 3.0 Assessment 01/11/2026 5.2 / 4.0 Assessment 11/11/2026 5.1 / 4.4 Assessment 15/11/2026 5.1 / 4.4 Assessment 20/11/2026 5.1 / 4.8 Current
Only actual published assessments are shown. Distances reflect scores, not elapsed time. A score change is not the stock’s return.
The comparison uses the same data as the company pages and refreshes with their website updates. Market-price changes do not automatically recalculate the scores. Missing ratings are shown as — and are excluded from the chart.